Shock waves or needles? new trial pits two tennis elbow therapies Head-to-Head

NCT ID NCT07043335

Recruiting now Symptom relief Sponsor: Haydarpasa Numune Training and Research Hospital Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether mesotherapy (injecting a mix of medicines into the skin) works as well as shock wave therapy for tennis elbow. Fifty adults with elbow pain for at least 6 weeks will be randomly assigned to one of the two treatments. Researchers will measure pain, grip strength, and quality of life before treatment, right after, and 12 weeks later.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: mesotherapy (lidocaine, pentoxifylline, meloxicam, thiocolchicoside)
What this could lead to: If it works, this could offer a new, non-surgical option for easing tennis elbow pain and improving function.
What could go wrong: This is a small, early-stage trial with only 50 people, so results may not apply to everyone. It compares two treatments but doesn't test against a placebo or no treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LATERAL EPICONDYLITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

epicondylitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LATERAL EPICONDYLITIS TENNIS ELBOW

Contacts and locations

Locations

Health Science University Haydarpasa Numune Research and Training Hospital, Istanbul, Uskudar 34668
RECRUITING

Istanbul, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.